Table 1 Patient preoperative demographics
90-d survivors | 90-d non-survivors | p-value | |
|---|---|---|---|
Age (yrs) | 35.1 ± 7.7 | 34.5 ± 10.6 | 0.926 |
Female | 6 (33.3%) | 1 (50%) | 0.639 |
BMI | 23.8 ± 4.7 | 23.1 ± 0.42 | 0.851 |
Diabetes mellitus | 1 (5.6%) | 0 | 0.732 |
NYHA stage | 3.28 ± 0.9 | 4.0 ± 0 | 0.005 |
Renal insufficiency | 5 (33.3%) | 1 (50%) | 0.199 |
Hepatitis B | 11 (73.3%) | 1 (50%) | 0.496 |
HIV | 1 (5.6%) | 1 (50%) | 0.047 |
Previous CVA | 1 (5.6%) | 0 | 0.732 |
Vegetation | 15 (93.8%) | 2 (100%) | 0.716 |
Previous endocarditis | 1 (5.6%) | 0 | 0.732 |
GFR (mL/min/1.73 m2) | 89.2 ± 43.2 | 82.5 ± 82.7 | 0.848 |
Creatinine (mg/dL) | 1.9 ± 2.4 | 2.3 ± 2.1 | 0.855 |
Urea (mg/dL) | 73.1 ± 60.4 | 73.5 ± 51.6 | 0.992 |
GGT (U/L) | 88.4 ± 69.7 | 18.5 ± 0.7 | 0.186 |
ALT (U/L) | 57.9 ± 43.6 | 10.5 ± 0.7 | 0.154 |
AST (U/L) | 107.6 ± 121.3 | 258.5 ± 334.5 | 0.182 |
Bilirubin (mg/dL) | 1.62 ± 3.05 | 0.6 ± 0.35 | 0.636 |
Patient’s preoperative blood culture profile | 0.504 | ||
Negative (marantic endocarditis) | 4 (22.2%) | 0 | |
Staphylococcus aureus | 6 (33.3%) | 2 (100%) | |
Enterococcus | 2 (11.1%) | 0 | |
Coagulase negative Staphylococcus | 2 (11.1%) | 0 | |
Streptococcus species | 4 (22.2%) | 0 | |
EuroSCORE II | 6.89 ± 3.35 | 11.04 ± 3.35 | 0.036 |